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and protein diet added 47 and 2%, respectively, to the feeding 
value when compared with the corn control. The diet intended 
to reconstruct WDGS40 from fiber, protein, fat, and solu-
bles gave similar performance for G:F (P  0.83). However, 
WDGS40 cattle had greater fat (P = 0.05) and tended to have 
greater marbling (P = 0.17). The combination of the individ-
ual components mimics the feeding value of WDGS with the 
largest contributor being protein.
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Metritis is a frequent problem in postpartum dairy cows. In-
trauterine therapy with oxytetracycline (OTC) is often used 
to improve therapeutic outcomes, although efficacy data 
supporting this therapy are ambiguous. Several manuscripts 
describe the depletion of OTC from milk following intrauter-
ine therapy. However, none of these studies have correlated 
uterine severity scores with milk OTC concentrations using 
highly sensitive detection systems. Our objective was to do 
this to test the hypothesis that cows with more severe uter-
ine severity would have higher OTC residues in milk follow-
ing intrauterine therapy. Thirty-two cows received a single 
treatment of 4 g of OTC via intrauterine infusion. Blood and 
milk samples were collected before intrauterine therapy and 
throughout the trial period of 96 h after infusion. Uterine se-
verity scores were assigned at initiation of therapy and every 
24 h throughout the remainder of the trial. Plasma and milk 
samples were analyzed for OTC concentrations using liquid 
chromatography coupled with mass spectrometry. Following 
treatment, OTC rapidly diffused from the uterus to plasma and 
from plasma to milk. Maximum concentration in plasma and 
milk occurred within 24 h following intrauterine infusion and 
18 of the cows still had detectable levels of OTC in milk 4 d 
after intrauterine infusion. Greater uterine severity score at the 
initiation of treatment showed a significant positively correla-
tion with higher milk OTC concentration at the second milk-
ing following treatment (R2 = 0.46, P = 0.01) but there was 
no correlation between initial uterine severity score and OTC 
concentration at the conclusion of the study (R2 = 0.06, P = 
0.75). In the United States, intrauterine administration of OTC 
is considered to be an extra-label therapy. The use of uterine 
severity score can be used to predict OTC concentration in the 
first day following therapy but should not be used as a predic-
tor of OTC concentrations 96 h after treatment. Dairy produc-
ers should consult with their veterinarian to develop strategies 
that will prevent the presence of violative residues of OTC in 
bulk tank milk following intrauterine therapy.
Key Words: bovine metritis, drug residues
doi: 10.2527/msasas2016-065
066	 Midwest	dairy	processing	needs,	trends,	and	
changes. V. V. Mistry*, South Dakota State  
University, Brookings.
The general trend in the U.S. dairy industry over the years 
has been that of consolidation, and this has been reflected in 
the Midwest as well. The total number of dairy farms in the 
United States has dropped approximately 668% since 1980. 
The whole-herd buyout program that began in 1985 to reduce 
the milk supply in the country and improve prices resulted in 
a drop in cow numbers by approximately 1 million in just 5 
yr. Subsequently, in the previous 2 decades, there has been a 
general increase in the demand for milk products, presenting 
opportunities for the dairy industry. Although there have been 
definite differences in demand for specific products, the gen-
eral trends reflect an increase. A recent study by Bliming and 
Associates, Inc., “Path Forward,” sponsored by the Midwest 
Dairy Association, has shown that the Midwest has the po-
tential to capitalize on the growing domestic and global dairy 
demand opportunities. According to this study, the region’s 
existing land and water infrastructure, business climate, and 
capital resource availability are the key ingredients that will 
help support the anticipated dairy market growth of 15% by 
2022. Much of this growth has already been occurring in some 
parts of the Midwest. For example, in South Dakota, after a de-
cline in dairy farm numbers in the period following 1985 from 
4400 to 273 in 2013 and a record low of 79,000 cows in 2004, 
the cow numbers have increased to 107,000 and are expected 
to grow further in response to anticipated processing growth 
and demand for products. In 2013, there were 8 cheese plants, 
which include 2 large cheese and whey processors, a drying 
facility, and several others. In response to the positive growth 
opportunities, a new $100 million cheese plant was built in 
the state in 2014. Two existing cheese plants have also under-
gone substantial expansions in cheese- and whey-processing 
capabilities. The state ranks eighth in cheese production and 
accounts for approximately 24% of all cheese produced. These 
plants collectively manufacture natural commodity cheeses 
that are exported outside of the Midwest and used as table 
cheeses or for further processing. Other products such as dried 
whey ingredients, including lactose, are also manufactured, 
largely for export. To support this growing industry, there is 
a strong need for dairy graduates. The check-off funds–spon-
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